Page last updated: 2024-10-25

eucalyptol and Glioma

eucalyptol has been researched along with Glioma in 1 studies

Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Research Excerpts

ExcerptRelevanceReference
"Glioma is the most common primary intracranial tumor, in which glioblastoma (GBM) is the most malignant and lethal."1.62Eucalyptal A inhibits glioma by rectifying oncogenic splicing of MYO1B mRNA via suppressing SRSF1 expression. ( Hua, D; Jiang, Z; Luo, W; Shi, C; Sun, C; Tang, S; Wang, L; Wang, Q; Wang, W; Yu, H; Yu, L; Yu, S; Yu, Y; Zhang, D; Zhao, Q; Zhou, X, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hua, D1
Zhao, Q1
Yu, Y1
Yu, H1
Yu, L1
Zhou, X1
Wang, Q1
Sun, C1
Shi, C1
Luo, W1
Jiang, Z1
Wang, W1
Wang, L1
Zhang, D1
Tang, S1
Yu, S1

Other Studies

1 other study available for eucalyptol and Glioma

ArticleYear
Eucalyptal A inhibits glioma by rectifying oncogenic splicing of MYO1B mRNA via suppressing SRSF1 expression.
    European journal of pharmacology, 2021, Jan-05, Volume: 890

    Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Carcinogenesis; Cell Line, Tumor; Drugs

2021